In our study, we found an increased risk of CVE associated with the use of ipratropium bromide in patients with COPD. We found a significant effect of recency of exposure to ipratropium bromide on ...

or nebulization (7%), or ipratropium bromide in a fixed-dose combination with albuterol (38%). Overall, exposure to anticholinergics was associated with a 29% higher risk of CVEs relative to no ...

Short-acting beta-agonists (SABAs) are a class of prescription drugs used to quickly relieve shortness of breath and wheezing in people with asthma. SABAs work by relaxing the smooth muscles of the ...